↓ Skip to main content

Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report

Overview of attention for article published in Journal of Medical Case Reports, December 2014
Altmetric Badge

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report
Published in
Journal of Medical Case Reports, December 2014
DOI 10.1186/1752-1947-8-416
Pubmed ID
Authors

Abou Dao, Nadia Benchakroun, Hamza Jabir, Amina Taleb, Zineb Bouchbika, Nezha Tawfiq, Hassan Jouhadi, Souha Sahraoui, Abdellatif Benider

Abstract

Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability of chemotherapy or targeted therapy, and to a lack of financial resources or surgeons' lack of knowledge of other therapeutic options.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
United States 1 5%
Unknown 18 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 25%
Student > Ph. D. Student 4 20%
Student > Master 2 10%
Student > Doctoral Student 2 10%
Other 1 5%
Other 2 10%
Unknown 4 20%
Readers by discipline Count As %
Medicine and Dentistry 10 50%
Agricultural and Biological Sciences 2 10%
Nursing and Health Professions 1 5%
Sports and Recreations 1 5%
Psychology 1 5%
Other 0 0%
Unknown 5 25%